Tilray to expand presence in Italy through partnership

Mr. Rajnish Ohri reports TILRAY MEDICAL FORMS STRATEGIC PARTNERSHIP IN ITALY TO BROADEN ACCESS TO MEDICAL CANNABIS EXTRACTS Tilray Brands Inc. division Tilray Medical's wholly owned subsidiary, FL Group SRL, has entered into a strategic partnership with L. Molteni & C. dei F.lli Alitti Societa di Esercizio SpA, an Italian pharmaceutical firm specializing in pain therapies and substance dependence. The partnership is designed to broaden the availability of Tilray Medical cannabis extracts for patients across Italy. Molteni will collaborate with FL Group by providing targeted education on medical cannabis therapies through Molteni's comprehensive network of pharmaceutical, scientific and medical professionals throughout Italy. "This partnership reflects our commitment to advancing patient care through strategic collaboration," said Rajnish Ohri, managing director, international, at Tilray Brands. "By combining FL Group's regulatory and distribution capabilities with Molteni's scientific leadership, we are not only expanding access to high-quality, EU-GMP-certified cannabis therapies for patients across Italy but also prioritizing medical cannabis education for pain therapies. Through Molteni's extensive network of health care professionals, we aim to empower practitioners with the knowledge and resources needed to support patients seeking effective pain management solutions." Tilray Medical continues to lead the European medical cannabis market with operations in Germany, Italy, Portugal, Poland and the United Kingdom. About Tilray Medical Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, Symbios and Navcora. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the largest suppliers of medical cannabis to patients, physicians, hospitals, pharmacies, researchers and governments in 20 countries and across five continents. About Tilray Brands Inc. Tilray Brands is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages. About Molteni Farmaceutici Molteni Farmaceutici is an Italian pharmaceutical company, a specialty pharma leader in therapeutics solutions for pain management and drug addiction. Founded in 1892 and headquartered in Florence, Italy. With its own manufacturing, R&D (research and development), regulatory, supply chain and commercial capabilities it is able to serve a broad distribution reach in Europe and across the globe, with operations in over 40 countries. We seek Safe Harbor.